NCT04764513 Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT Status UNKNOWN Phase PHASE1/PHASE2
NCT04762875 MGTA-145 + Plerixafor in the Mobilization of HSCs for Allogeneic Transplant in Hematologic Malignancies Status TERMINATED Phase PHASE2
NCT04747912 Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO) Status SUSPENDED Phase PHASE2
NCT04732845 Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04726241 The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study Status RECRUITING Phase PHASE1/PHASE2
NCT04699162 Efficacy of Intermediate and High Intensity Regimens in Patients With Relapsed Acute Lymphoblastic Leukemia Status COMPLETED Phase N/A
NCT04689204 A Study of CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological Malignancies Status COMPLETED Phase EARLY_PHASE1
NCT04677231 Evaluation of Long-term Health Status and Quality of Life in Adult Survivors With Philadelphia-negative Acute Lymphoblastic Leukemia/Lymphoma Treated With an Intensive Pediatric or Pediatric-inspired Protocol Status UNKNOWN Phase N/A
NCT04635384 Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04629430 Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT Status COMPLETED Phase NA
NCT04606433 Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04537871 Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04532281 A Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies Status RECRUITING Phase EARLY_PHASE1
NCT04532268 A Study of Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHL Status RECRUITING Phase EARLY_PHASE1
NCT04532203 A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies Status RECRUITING Phase EARLY_PHASE1
NCT04524455 Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL Status COMPLETED Phase PHASE1